Our 2022 program has been created and tailored to explore a whole host of brand-new topics including learning how to tailor your regulatory drug development approach for swift approvals, dissecting the neurodegenerative drug development investing landscape and uncovering the potential of precision neurology.
Back to All Events
Earlier Event: June 15
ISSCR Annual Meeting
Later Event: June 27
TCR-based Therapies for Solid Tumors